Even-Sapir Einat, Lerman Hedva, Lievshitz Genady, Khafif Avi, Fliss Dan M, Schwartz Arnon, Gur Eyal, Skornick Yehuda, Schneebaum Shlomo
Department of Nuclear Medicine, Tel-Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
J Nucl Med. 2003 Sep;44(9):1413-20.
Lymphoscintigraphy is performed before sentinel node (SN) biopsy for SN mapping. It is of clinical importance mainly if the tumor is located in body parts with ambiguous lymph node drainage. The purpose of this study was to assess the clinical benefit of fused SPECT/CT images to planar images for SN mapping.
Thirty-four consecutive patients with cutaneous malignant melanoma (n = 28) and squamous cell carcinoma (n = 6) and scheduled for SN biopsy were enrolled. Primary tumors were located in the trunk (n = 12), in the extremities (n = 12), in the head and neck (n = 9), and in the penis (n = 1). Scintigraphy was performed using a hybrid gamma-camera/low-dose CT system. Planar images and fused SPECT/CT images were interpreted separately.
SPECT/CT identified multiple draining basins in 6 of 12 patients (50%) with trunk melanoma and in 3 of 9 patients (33%) with head and neck melanoma or mucosal tumor. In 9 of 21 patients (43%) with a primary tumor located in the head and neck or trunk region, SPECT/CT-fused images identified SNs that were missed on planar images, 2 of which were involved with tumor. Three of the 9 nodes were located close to the injection site and were hidden by its scattered radiation, and 2 were in-transit nodes. Another 4 nodes, identified on fused images only, were located in an additional basin to those identified on planar images. Fused images were of no added value either in patients with limb melanoma or in a patient with a penile melanoma.
SPECT/CT SN mapping provides additional data that are of clinical relevance to SN biopsy in patients with trunk or head and neck melanoma and in patients with mucosal head and neck tumor.
在进行前哨淋巴结(SN)活检以进行SN定位之前,需进行淋巴闪烁显像。主要在肿瘤位于淋巴结引流不明确的身体部位时,其具有临床重要性。本研究的目的是评估融合的SPECT/CT图像相对于平面图像在SN定位中的临床益处。
连续纳入34例计划进行SN活检的皮肤恶性黑色素瘤患者(n = 28)和鳞状细胞癌患者(n = 6)。原发肿瘤位于躯干(n = 12)、四肢(n = 12)、头颈部(n = 9)和阴茎(n = 1)。使用混合型γ相机/低剂量CT系统进行闪烁显像。分别解读平面图像和融合的SPECT/CT图像。
SPECT/CT在12例躯干黑色素瘤患者中的6例(50%)以及9例头颈部黑色素瘤或黏膜肿瘤患者中的3例(33%)中识别出多个引流区域。在21例原发肿瘤位于头颈部或躯干区域的患者中的9例(43%)中,SPECT/CT融合图像识别出平面图像上遗漏的前哨淋巴结,其中2个有肿瘤累及。9个淋巴结中的3个位于注射部位附近,被其散射辐射遮挡,2个为途中淋巴结。另外4个仅在融合图像上识别出的淋巴结位于平面图像识别出的区域之外的另一个引流区域。融合图像在肢体黑色素瘤患者或阴茎黑色素瘤患者中均无附加价值。
SPECT/CT前哨淋巴结定位为躯干或头颈部黑色素瘤患者以及头颈部黏膜肿瘤患者的前哨淋巴结活检提供了具有临床相关性的额外数据。